Questions we revisit
The page returns to unresolved issues when new data, partnerships, filings, trials or technical documents change the picture.
GenoMethods follows Merck through methods, milestones, datasets and questions that decide real value.
The biology around Merck is only one part of the story; implementation matters as much.
A tag page like this links company news to the technical substrate beneath it, including candidate selection, clinical endpoints, trial design, safety signals and manufacturing.
As the field moves, this page will help separate durable advances from temporary attention, with the wider context collected under Drug Discovery.
The page returns to unresolved issues when new data, partnerships, filings, trials or technical documents change the picture.
The most useful material explains how the method performs, where it fails and what assumptions sit inside the workflow.
A claim becomes stronger when it survives comparison, scale, safety review and routine use beyond the first demonstration.